Viking Therapeutics got the market's attention with robust phase 2 results for VK2735, a potential weight loss therapy.
Viking Therapeutics stock jumped higher last year because it looks like a dual GLP-1/GIP agonist it's developing could ...
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.